Literature DB >> 16856156

Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.

Maureen M O'Brien1, Youngna Lee-Kim, Tracy I George, Kenneth L McClain, Clare J Twist, Michael Jeng.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome which can be an inherited congenital disorder or can develop secondary to malignancy, infection, or autoimmune disease. Secondary HLH due to malignancy occurs most commonly with T or NK-cell lymphoid neoplasms. HLH with B-cell malignancies is less common and HLH has rarely been described in association with precursor B-cell acute lymphoblastic leukemia (B-ALL). We report three cases of HLH associated with B-ALL and review 17 cases of ALL-associated HLH previously reported in the literature. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 16856156     DOI: 10.1002/pbc.20950

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Hemophagocytic lymphohistiocytosis during maintenance treatment of precursor B-cell acute lymphoblastic leukemia.

Authors:  Akiyo Furutani; Toshihiko Imamura; Ikuyo Ueda; Mami Takanashi; Yoshifumi Hirashima; Takuya Nakatani; Tohru Inaba; Akira Morimoto
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

2.  Hemophagocytic lymphohistiocytosis in B-cell lymphoproliferative disorder: report of a rare association.

Authors:  Deepti Aggarwal; Ruchika Gupta; Sompal Singh; Kusum Gupta; Madhur Kudesia
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-07       Impact factor: 0.900

Review 3.  Hemophagocytic Syndrome and Critical Illness: New Insights into Diagnosis and Management.

Authors:  Zuzana Tothova; Nancy Berliner
Journal:  J Intensive Care Med       Date:  2014-01-08       Impact factor: 3.510

Review 4.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

5.  Hemophagocytic lymphohistiocytosis with MUNC13-4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemia.

Authors:  Tamara Y Chang; Julie Jaffray; Bruce Woda; Peter E Newburger; G Naheed Usmani
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

6.  A novel model for IFN-γ-mediated autoinflammatory syndromes.

Authors:  R Lee Reinhardt; Hong-Erh Liang; Katherine Bao; April E Price; Markus Mohrs; Ben L Kelly; Richard M Locksley
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

7.  Acute myelocytic leukemia in a patient with hemophagocytic lymphohistiocytosis: A case report.

Authors:  Defeng Zhao; Liren Qian; Jianliang Shen
Journal:  Oncol Lett       Date:  2014-09-12       Impact factor: 2.967

8.  Potential therapeutic targets and small molecular drugs for pediatric B-precursor acute lymphoblastic leukemia treatment based on microarray data.

Authors:  Limei Kong; Xiaowei Zhang; Chao Li; Liping Zhou
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

Review 9.  Hemophagocytic Lymphohistiocytosis and Relapsing Polychondritis with Acute Myelogenous Leukemia: Case Report and Review of the Literature.

Authors:  Hamza M Alsaid; Adnan A M Wahdan; Ihab N Tahboub; Nour M Almakadma
Journal:  Am J Case Rep       Date:  2020-08-19

10.  STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia.

Authors:  Shella Saint Fleur-Lominy; Mate Maus; Martin Vaeth; Ingo Lange; Isabelle Zee; David Suh; Cynthia Liu; Xiaojun Wu; Anastasia Tikhonova; Iannis Aifantis; Stefan Feske
Journal:  Cell Rep       Date:  2018-09-11       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.